Biotech & MedTech
-
Steve Saviuk on how Valeo Pharma’s ‘life changing’ products have delivered the strong growth forecasted for 2022
In this InvestorIntel interview, Tracy Weslosky interviews Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO and…
-
Valeo Pharma keeps delivering with a 100% revenue growth forecast in 2022 and more new effective pharmaceuticals
Early in 2022 InvestorIntel updated readers about a company that was growing its revenue at an incredible rate…
-
Cardiol Therapeutics is concerned with affairs of the heart
One thing I really enjoy about writing for InvestorIntel is all the random learning I get from reading…
-
Focused on a better future, Siva’s cancer tumor therapy system selects Sona’s gold nanorod for delivery
Today we are going to talk about a company that is making progress in the targeted treatment of…
-
Hemostemix adds depth and strength to its scientific bench on the road to commercialization
Since we last covered Hemostemix where they released the promising results of their retrospective study of heart disease…
-
Steve Saviuk of Valeo Pharma talks about acquiring new therapeutic drugs and record Q3 revenue
In this interview, InvestorIntel Publisher and Editor in Chief Stephen Lautens talks to Valeo Pharma Inc.’s (TSX: VPH…
-
Greg Fenton of Zentek on its new mask manufacturing agreement and US interest in its HVAC filters
In this InvestorIntel interview, host Tracy Weslosky talks to Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and…
-
Zentek sets its sights on treating skin conditions as it expands potential uses for its ZenGUARD graphene coating
As the world becomes increasingly interconnected, we have seen how the risks of disease transmission have also increased.…
